Pharma 2020: Challenging Business Models
Pharma’s fully integrated business model is under huge pressure and
by 2020 no pharma company will be able to ‘profit alone’; instead,
companies will have to collaborate with other organisations, both inside
and outside the sector. A recent report puts forward two business models
that are likely to emerge as companies prepare for this future.
By Jo Pisani and Steve Arlington at PricewaterhouseCoopers (September 2009)
Keywords: business models, pharma, profit, federated model, management hub, big pharma, federation